Did Dave McCormick Invest in China and Then Want to Ban Fentanyl

It's worth noting that Dave McCormick, a former hedge fund executive and US Senate candidate, has been accused of investing in China.

He did indeed invest in a Chinese company called Hillhouse Capital.

But here's the thing: some people claim that after investing in China, McCormick later advocated for banning fentanyl.

Dave McCormick's hedge fund, Bridgewater Associates, made hundreds of thousands of dollars in investments in subsidiaries of the Aviation Industry Corporation of China, or AVIC. AVIC designs and produces China's military aircraft, including the future H-20 flying wing stealth bomber.

Bridgewater also invested in Aisino Corp, a subsidiary of the China Aerospace Science and Industry Corporation, or CASIC. CASIC is China's largest missile designer and manufacturer.

As CEO of Bridgewater, McCormick led the fund to hold more than $200 million in stock in at least 20 Chinese companies that were later sanctioned by the US for being part of China's military industrial complex. These investments were made during his time with the company, starting in 2017.

See what others are reading: China Integrated Circuit Industry Investment Fund

Bridgewater's investments in Chinese companies grew during McCormick's time with the company, and the fund held millions in stock in companies that produced military equipment. The investments were later stopped after sanctions were imposed, but not before the fund had made significant profits.

In 2021, seven Bridgewater Associates hedge funds held close to $1.7 million in stock in Humanwell Healthcare, China's largest fentanyl producer. This investment was made while McCormick was CEO of Bridgewater Associates.

Additional reading: Russia-China Investment Fund

Dave McCormick's investment activities in China have sparked controversy and criticism.

Some critics argue that McCormick's investment in Hillhouse Capital's fund, which invests in Chinese companies, raises concerns about his potential ties to the Chinese government.

McCormick has also faced criticism for his role as a board member at Bridgewater Associates, which manages a significant portion of the Chinese government's foreign exchange reserves, according to the article.

This has led some to question McCormick's judgment and loyalty to the United States.

Dave McCormick has been vocal about his opposition to Chinese fentanyl, calling it a "terrorist threat" and an "insidious attack on America." He's even compared treating it to nuclear plutonium.

In April, McCormick spoke at a Polaris National Security event in Pittsburgh, where he promised to take action against China's fentanyl production. He suggested interdicting ships and treating fentanyl like nuclear plutonium.

However, federal tax forms reveal a different story. While serving as CEO of Bridgewater Associates, McCormick's hedge fund invested in China's largest fentanyl producer, Humanwell Healthcare. Seven Bridgewater Associates hedge funds held close to $1.7 million in stock in Humanwell Healthcare in 2021.

This investment is now being questioned, given McCormick's current stance on fentanyl. His super PAC recently launched a $30 million ad campaign promising to stop the flow of fentanyl into the country.

Related reading: Dave Mccormick Hedge Fund

Dave McCormick's former company, Bridgewater Associates, invested hundreds of thousands of dollars in subsidiaries of the Aviation Industry Corporation of China, or AVIC, which designs and produces China's military aircraft.

McCormick was CEO of Bridgewater in 2020, and the investments were made during his tenure. AVIC is responsible for designing and producing China's military aircraft, including the future H-20 flying wing stealth bomber.

Bridgewater also made investments in Aisino Corp, a subsidiary of the China Aerospace Science and Industry Corporation, or CASIC, which is China's largest missile designer and manufacturer.

The investments in these companies were made when McCormick was leading Bridgewater Associates, and the company held more than $200 million in stock in at least 20 Chinese companies that were later sanctioned by the United States for being part of China's military industrial complex.

McCormick has since said that Bridgewater's decision to stop the investments after sanctions were imposed highlighted the need for stricter federal rules around China.

David McCormick's investments in China's military companies have been a topic of debate. FACT CHECK TRUE: DAVID MCCORMICK INVESTED IN CHINESE MILITARY COMPANIES. The documents show that Bridgewater Associates, led by McCormick, made investments in subsidiaries of the Aviation Industry Corporation of China (AVIC).

Take a look at this: David Tepper Rock Hill

AVIC designs and produces China's military aircraft, including the future H-20 flying wing stealth bomber. The U.S. Department of Defense confirms this.

In 2020, Bridgewater made hundreds of thousands of dollars in investments in AVIC subsidiaries. This is according to the documents found by WGAL.

Here are some key facts about McCormick's investments:

These facts confirm that David McCormick did invest in Chinese military companies.